Cyclophosphamide, methotrexate, and fluorouracil: still the gold standard?
CA Hudis
JCO Jul 1 1996: 1971–1973. [PDF]
	Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma
	MS Kaminski, KR Zasadny, IR Francis, MC Fenner, CW Ross, AW Milik, J Estes, M Tuck, D Regan, S Fisher, SD Glenn, and RL Wahl
	JCO Jul 1 1996: 1974–1981. [Abstract] [PDF]
	Sequential methotrexate and fluorouracil for the treatment of node- negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil
	B Fisher, J Dignam, EP Mamounas, JP Costantino, DL Wickerham, C Redmond, N Wolmark, NV Dimitrov, DM Bowman, AG Glass, JN Atkins, N Abramson, CM Sutherland, BS Aron, and RG Margolese
	JCO Jul 1 1996: 1982–1992. [Abstract] [PDF]
	Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity [published erratum appears in J Clin Oncol 1996 Dec;14(12):3175]
	C Wasserheit, A Frazein, R Oratz, J Sorich, A Downey, H Hochster, A Chachoua, J Wernz, A Zeleniuch-Jacquotte, R Blum, and J Speyer
	JCO Jul 1 1996: 1993–1999. [Abstract] [PDF]
	Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group
	A Buzdar, W Jonat, A Howell, SE Jones, C Blomqvist, CL Vogel, W Eiermann, JM Wolter, M Azab, A Webster, and PV Plourde
	JCO Jul 1 1996: 2000–2011. [Abstract] [PDF]
	Limited-sampling models for irinotecan pharmacokinetics- pharmacodynamics: prediction of biliary index and intestinal toxicity
	R Mick, E Gupta, EE Vokes, and MJ Ratain
	JCO Jul 1 1996: 2012–2019. [Abstract] [PDF]
	Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study
	GG Chabot, JP Armand, C Terret, M de Forni, D Abigerges, B Winograd, L Igwemezie, L Schacter, S Kaul, J Ropers, and M Bonnay
	JCO Jul 1 1996: 2020–2030. [Abstract] [PDF]
	Systemic administration of recombinant interferon alfa in carcinoma patients upregulates the expression of the carcinoma-associated antigens tumor-associated glycoprotein-72 and carcinoembryonic antigen
	M Roselli, F Guadagni, O Buonomo, A Belardi, V Vittorini, R Mariani-Costantini, JW Greiner, CU Casciani, and J Schlom
	JCO Jul 1 1996: 2031–2042. [Abstract] [PDF]
	Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy
	A Tiersten and LB Saltz
	JCO Jul 1 1996: 2043–2046. [Abstract] [PDF]
	Surgery for lung metastases from colorectal cancer: analysis of prognostic factors
	P Girard, M Ducreux, P Baldeyrou, P Rougier, T Le Chevalier, J Bougaran, P Lasser, B Gayet, P Ruffie, and D Grunenwald
	JCO Jul 1 1996: 2047–2053. [Abstract] [PDF]
	Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial
	DH Johnson, DM Paul, KR Hande, Y Shyr, C Blanke, B Murphy, M Lewis, and RF De Vore, 3rd
	JCO Jul 1 1996: 2054–2060. [Abstract] [PDF]
	Bilateral germ cell testicular tumors in New Zealand: experience in Auckland and Christchurch 1978-1994
	BM Colls, VJ Harvey, L Skelton, PI Thompson, and CM Frampton
	JCO Jul 1 1996: 2061–2065. [Abstract] [PDF]
	Correlation between polysialic-neural cell adhesion molecule levels in CSF and medulloblastoma outcomes
	D Figarella-Branger, C Dubois, P Chauvin, B De Victor, JC Gentet, and G Rougon
	JCO Jul 1 1996: 2066–2072. [Abstract] [PDF]
	Disease course and late sequelae of Langerhans' cell histiocytosis: 25- year experience at the University of California, San Francisco
	B Willis, A Ablin, V Weinberg, S Zoger, WM Wara, and KK Matthay
	JCO Jul 1 1996: 2073–2082. [Abstract] [PDF]
	Randomized, double-blind, placebo-controlled trial comparing the response rates of carmustine, dacarbazine, and cisplatin with and without tamoxifen in patients with metastatic melanoma. National Cancer Institute of Canada Clinical Trials Group
	JJ Rusthoven, IC Quirt, NA Iscoe, PB McCulloch, KW James, RC Lohmann, J Jensen, S Burdette-Radoux, AJ Bodurtha, HK Silver, S Verma, GR Armitage, B Zee, and K Bennett
	JCO Jul 1 1996: 2083–2090. [Abstract] [PDF]
	Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis
	B Mellado, D Colomer, T Castel, M Munoz, E Carballo, M Galan, JM Mascaro, JL Vives-Corrons, JJ Grau, and J Estape
	JCO Jul 1 1996: 2091–2097. [Abstract] [PDF]
	Malignant mesothelioma following treatment for Hodgkin's disease
	LB Weissmann, JM Corson, AI Neugut, and KH Antman
	JCO Jul 1 1996: 2098–2100. [Abstract] [PDF]
	Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer
	G Kemp, P Rose, J Lurain, M Berman, A Manetta, B Roullet, H Homesley, D Belpomme, and J Glick
	JCO Jul 1 1996: 2101–2112. [Abstract] [PDF]
	Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group
	SB Kaye, J Paul, J Cassidy, CR Lewis, ID Duncan, HK Gordon, HC Kitchener, DJ Cruickshank, RJ Atkinson, M Soukop, EM Rankin, JA Davis, NS Reed, SM Crawford, A MacLean, D Parkin, TK Sarkar, J Kennedy, and RP Symonds
	JCO Jul 1 1996: 2113–2119. [Abstract] [PDF]
	p53 and bcl-2 proteins as prognostic markers in human papillomavirus- associated cervical lesions
	K Kurvinen, K Syrjanen, and S Syrjanen
	JCO Jul 1 1996: 2120–2130. [Abstract] [PDF]
	Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study
	MH Kramer, J Hermans, J Parker, AD Krol, JC Kluin-Nelemans, HL Haak, K van Groningen, JH van Krieken, D de Jong, and PM Kluin
	JCO Jul 1 1996: 2131–2138. [Abstract] [PDF]
	Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma
	A Saven, T Lee, M Kosty, and L Piro
	JCO Jul 1 1996: 2139–2144. [Abstract] [PDF]
	Carboxypeptidase G2 rescue after high-dose methotrexate
	LM DeAngelis, WP Tong, S Lin, M Fleisher, and JR Bertino
	JCO Jul 1 1996: 2145–2149. [Abstract] [PDF]
	Granulocyte-macrophage colony-stimulating factor associated with induction treatment of acute myelogenous leukemia: a randomized trial by the European Organization for Research and Treatment of Cancer Leukemia Cooperative Group
	R Zittoun, S Suciu, F Mandelli, T de Witte, J Thaler, P Stryckmans, M Hayat, M Peetermans, M Cadiou, G Solbu, MC Petti, and R Willemze
	JCO Jul 1 1996: 2150–2159. [Abstract] [PDF]
	Oral cladribine as primary therapy for patients with B-cell chronic lymphocytic leukemia
	G Juliusson, I Christiansen, MM Hansen, S Johnson, E Kimby, A Elmhorn- Rosenborg, and J Liliemark
	JCO Jul 1 1996: 2160–2166. [Abstract] [PDF]
	Survival of multiple myeloma patients who are potential candidates for early high-dose therapy intensification/ autotransplantation and who were conventionally treated
	J Blade, JF San Miguel, M Fontanillas, A Alcala, J Maldonado, J Garcia-Conde, E Conde, G Conzalez-Brito, MJ Moro, ML Escudero, J Trujillo, A Pascual, C Rozman, J Estape, and E Montserrat
	JCO Jul 1 1996: 2167–2173. [Abstract] [PDF]
	International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review
	BH Kushner, NK Cheung, MP LaQuaglia, PF Ambros, IM Ambros, MA Bonilla, M Ladanyi, and WL Gerald
	JCO Jul 1 1996: 2174–2180. [Abstract] [PDF]
	Challenges and opportunities of the Internet for medical oncology
	LM Glode
	JCO Jul 1 1996: 2181–2186. [Abstract] [PDF]
Adjuvant chemotherapy in pathologic Stage II nonseminomatous testicular cancer: are two cycles of etoposide-cisplatin a standard option?
S Culine and JP Droz
JCO Jul 1 1996: 2187–2188. [PDF]
Cytogenetic findings in T-cell lymphoma of angioimmunoblastic lymphadenopathy
A Younes
JCO Jul 1 1996: 2188–2189. [PDF]
Safety profile of single-dose dexamethasone premedication for paclitaxel
B Parikh, S Khanolkar, SH Advani, B Dhabhar, and M Chandra
JCO Jul 1 1996: 2189–2190. [PDF]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.